Cart is empty A new ‘hybrid’ hydrogel, which allows clinicians to safely deliver stem cells to the site of a brain injury in mice, has been developed by researchers from the University of Melbourne and the Australian National University.
Blood test for brain cancer may be on horizon, research finds
Glioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at Penn State College of Medicine have identified a biomarker that can be used in blood tests to diagnose GBM, track its progression and guide treatment. The researchers said that such a non-invasive liquid biopsy for GBM could help patients get the care they need more quickly.
Number of babies born preterm decreased slightly and stillborn rates unchanged during first wave of COVID-19 lockdowns
Babies born preterm decreased and stillborn rates remained unchanged during the first four months of COVID-19 lockdowns, according to a largescale international study.
Plugging immune cell leakage from tumors could improve skin cancer treatment
The number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumors, experiments in mice and human cells show.
Study finds common artificial sweetener linked to higher rates of heart attack and stroke
New Cleveland Clinic research showed that erythritol, a popular artificial sweetener, is associated with an increased risk of heart attack and stroke. Findings were published today in Nature Medicine.
For-profit hospices deliver lower quality care than nonprofit hospices, finds study
Patients receiving care from for-profit hospices have substantially worse care experiences than patients who receive care from not-for-profit hospices, according to a new RAND Corporation study.
Benefit of baricitinib for treatment of patients with moderately to severely active SLE is unclear
The work of a clinician-scientist often feels like two steps forward, one step back. Just ask Professor Eric Morand, Head of the School of Clinical Sciences at Monash University.
How the brain creates your taste in art
It has been said that there is no accounting for taste. But what if taste can actually be accounted for, and what if the things doing the accounting are the neural networks inside your brain?
Scientists reveal how different cancer cells ‘team up’ to help incurable childhood brain tumor spread
Scientists have shed light on how different types of cancer cells in an aggressive childhood brain cancer interact and work together to spread.
The antibodies from camels and sharks that could change medicine
Every four months, pathologist Aaron LeBeau scoops into a net one of the five nurse sharks he keeps in his University of Wisconsin lab. Then he carefully administers a shot to the animal, much like a pediatrician giving a kid a vaccine. The shot will immunize the shark against a human cancer, perhaps, or an infectious disease, such as COVID-19. A couple of weeks later, after the animal’s immune system has had time to react, LeBeau collects a small vial of shark blood.